Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity.
O'Flaherty, E
Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity. [electronic resource] - Leukemia & lymphoma Oct 1997 - 343-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1042-8194
10.3109/10428199709059689 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blood Preservation
Cell Count
Cell Survival--drug effects
Cells, Cultured
Cryopreservation
Cyclophosphamide--administration & dosage
Dose-Response Relationship, Drug
Epirubicin--administration & dosage
Erythroid Precursor Cells--drug effects
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cells--drug effects
Humans
Lymphoma, Non-Hodgkin--drug therapy
Phlebotomy
Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity. [electronic resource] - Leukemia & lymphoma Oct 1997 - 343-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1042-8194
10.3109/10428199709059689 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Blood Preservation
Cell Count
Cell Survival--drug effects
Cells, Cultured
Cryopreservation
Cyclophosphamide--administration & dosage
Dose-Response Relationship, Drug
Epirubicin--administration & dosage
Erythroid Precursor Cells--drug effects
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cells--drug effects
Humans
Lymphoma, Non-Hodgkin--drug therapy
Phlebotomy